{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"45"}],"units":"Participants"}],"description":"To estimate the overall survival of patients progression following prophylactic cellular immunotherapy after allogeneic hematopoietic stem cell therapy using low intensity conditioning for high-risk hematological malignancies.","groups":[{"description":"Reduced intensity conditioning consisting of Busulfan and Fludarabine(fludarabine 150 mg/m2 IV, busulfan 6 mg/kg IV, total lymphoid irradiation 2 Gy), followed by a rapid immunosuppressive taper of Tacrolimus (0.06 mg/kg q12h, PO, Days -7 to +28), Methotrexate (5 mg/m2, IV, Days +1, +3, +6, +11) and Mycophenolate Mofetil (10 mg/kg every 8 hours, PO, Days -6 to +7).","id":"OG000","title":"Immunosuppression Taper"}],"paramType":"NUMBER","populationDescription":"54 patients were enrolled however 9 patients did not receive planned donor lymphocyte infusion. 45 patients were analyzed.","reportingStatus":"POSTED","timeFrame":"2 Years","title":"Percentage of Patients Alive at 2 Years","type":"SECONDARY","unitOfMeasure":"percentage of participants"}